Antiviral Therapy for Hepatitis C Virus: Beyond the Standard of Care
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antiviral Therapy for Hepatitis C Virus: Beyond the Standard of Care
Authors
Keywords
-
Journal
Viruses-Basel
Volume 2, Issue 4, Pages 826-866
Publisher
MDPI AG
Online
2010-03-29
DOI
10.3390/v2040826
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A novel Hepatitis C virus p7 ion channel inhibitor, BIT225, inhibits bovine viral diarrhea virus in vitro and shows synergism with recombinant interferon-α-2b and nucleoside analogues
- (2010) Carolyn A. Luscombe et al. ANTIVIRAL RESEARCH
- In Vitro Activity and Preclinical Profile of TMC435350, a Potent Hepatitis C Virus Protease Inhibitor
- (2009) T.-I Lin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- MK-7009, a Potent and Selective Inhibitor of Hepatitis C Virus NS3/4A Protease
- (2009) N. J. Liverton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Preclinical Characterization of PF-00868554, a Potent Nonnucleoside Inhibitor of the Hepatitis C Virus RNA-Dependent RNA Polymerase
- (2009) S. T. Shi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- SCY-635, a Novel Nonimmunosuppressive Analog of Cyclosporine That Exhibits Potent Inhibition of Hepatitis C Virus RNA Replication In Vitro
- (2009) S. Hopkins et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Increased HDL Cholesterol and ApoA-I in Humans and Mice Treated With a Novel SR-BI Inhibitor
- (2009) David Masson et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The hepatitis C virus and its hepatic environment: a toxic but finely tuned partnership
- (2009) Marie Perrault et al. BIOCHEMICAL JOURNAL
- Cellular and molecular biology of HCV infection and hepatitis
- (2009) Hengli Tang et al. CLINICAL SCIENCE
- Albinterferon alfa-2b, a novel fusion protein of human albumin and human interferon alfa-2b, for chronic hepatitis C
- (2009) Vinod K. Rustgi CURRENT MEDICAL RESEARCH AND OPINION
- Rapid HCV-RNA Decline With Once Daily TMC435: A Phase I Study in Healthy Volunteers and Hepatitis C Patients
- (2009) Henk W. Reesink et al. GASTROENTEROLOGY
- The cyclophilin inhibitor Debio 025 combined with PEG IFNα2a significantly reduces viral load in treatment-naïve hepatitis C patients
- (2009) Robert Flisiak et al. HEPATOLOGY
- A phase III study of the safety and efficacy of viramidine versus ribavirin in treatment-naïve patients with chronic hepatitis C: ViSER1 results
- (2009) Yves Benhamou et al. HEPATOLOGY
- Statins potentiate thein vitroanti-hepatitis C virus activity of selective hepatitis C virus inhibitors and delay or prevent resistance development
- (2009) Leen Delang et al. HEPATOLOGY
- Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus-infected patients
- (2009) Simone Susser et al. HEPATOLOGY
- An Open Pilot Study Exploring the Efficacy of Fluvastatin, Pegylated Interferon and Ribavirin in Patients with Hepatitis C Virus Genotype 1b in High Viral Loads
- (2009) Hitomi Sezaki et al. INTERVIROLOGY
- The Isomerase Active Site of Cyclophilin A Is Critical for Hepatitis C Virus Replication
- (2009) Udayan Chatterji et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Hepatitis C virus cell entry: role of lipoproteins and cellular receptors
- (2009) M. E. Burlone et al. JOURNAL OF GENERAL VIROLOGY
- 1045 SAFETY AND ANTIVIRAL EFFICACY OF 14 DAYS OF THE CYCOPHILIN INHIBITOR NIM811 IN COMBINATION WITH PEGYLATED INTERFERON α2a IN RELAPSED GENOTYPE 1 HCV INFECTED PATIENTS
- (2009) E. Lawitz et al. JOURNAL OF HEPATOLOGY
- 1055 ANTIVIRAL ACTIVITY OF ANA598, A POTENT NON- NUCLEOSIDE POLYMERASE INHIBITOR, IN CHRONIC HEPATITIS C PATIENTS
- (2009) E. Lawitz et al. JOURNAL OF HEPATOLOGY
- 89 SAFETY, PLASMA PHARMACOKINETICS, AND ANTI-VIRAL ACTIVITY OF SCY-635 IN ADULT PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION
- (2009) S. Hopkins et al. JOURNAL OF HEPATOLOGY
- 88 PARTICULAR IN VITRO ANTI-HCV ACTIVITIES AND RESISTANCE PROFILE OF THE CYCLOPHILIN INHIBITOR DEBIO 025
- (2009) L. Coelmont et al. JOURNAL OF HEPATOLOGY
- 10 RESULTS OF A PROOF OF CONCEPT STUDY (C210) OF TELAPREVIR MONOTHERAPY AND IN COMBINATION WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE 4 HCV PATIENTS
- (2009) Y. Benhamou et al. JOURNAL OF HEPATOLOGY
- 95 EFFICACY AND SAFETY OF THE CYCLOPHILIN INHIBITOR DEBIO 025 IN COMBINATION WITH PEGYLATED INTERFERON ALPHA-2A AND RIBAVIRIN IN PREVIOUSLY NULL-RESPONDER GENOTYPE 1 HCV PATIENTS
- (2009) D.R. Nelson et al. JOURNAL OF HEPATOLOGY
- 50 ACTIVITY OF TELAPREVIR ALONE OR IN COMBINATION WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE 2 AND 3 HEPATITIS-C PATIENTS: INTERIM RESULTS OF STUDY C209
- (2009) G.R. Foster et al. JOURNAL OF HEPATOLOGY
- Substituted imidazopyridines as potent inhibitors of HCV replication
- (2009) Inge Vliegen et al. JOURNAL OF HEPATOLOGY
- Inhibition of Subgenomic Hepatitis C Virus RNA Replication by Acridone Derivatives: Identification of an NS3 Helicase Inhibitor
- (2009) Giuseppe Manfroni et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure-Based Discovery of Triphenylmethane Derivatives as Inhibitors of Hepatitis C Virus Helicase∞
- (2009) Chien-Shu Chen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of (R)-6-Cyclopentyl-6-(2-(2,6-diethylpyridin-4-yl)ethyl)-3-((5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl)-4-hydroxy-5,6-dihydropyran-2-one (PF-00868554) as a Potent and Orally Available Hepatitis C Virus Polymerase Inhibitor
- (2009) Hui Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- Identification of Hepatitis C Virus NS5A Inhibitors
- (2009) J. A. Lemm et al. JOURNAL OF VIROLOGY
- Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection
- (2009) Christophe Hézode et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection
- (2009) John G. McHutchison et al. NEW ENGLAND JOURNAL OF MEDICINE
- Essential Role of Cyclophilin A for Hepatitis C Virus Replication and Virus Production and Possible Link to Polyprotein Cleavage Kinetics
- (2009) Artur Kaul et al. PLoS Pathogens
- Clinical trial: randomized, double-blind, placebo-controlled study of nitazoxanide monotherapy for the treatment of patients with chronic hepatitis C genotype 4
- (2008) J. F. ROSSIGNOL et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Fluvastatin Inhibits Hepatitis C Replication in Humans
- (2008) Ted Bader et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Potential for Hepatitis C Virus Resistance to Nitazoxanide or Tizoxanide
- (2008) B. E. Korba et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Synergy of a Hepatitis C Virus (HCV) NS4A Antagonist in Combination with HCV Protease and Polymerase Inhibitors
- (2008) D. L. Wyles et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Debio 025, a Cyclophilin Binding Molecule, Is Highly Efficient in Clearing Hepatitis C Virus (HCV) Replicon-Containing Cells When Used Alone or in Combination with Specifically Targeted Antiviral Therapy for HCV (STAT-C) Inhibitors
- (2008) L. Coelmont et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Selection of Replicon Variants Resistant to ACH-806, a Novel Hepatitis C Virus Inhibitor with No Cross-Resistance to NS3 Protease and NS5B Polymerase Inhibitors
- (2008) W. Yang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Combinations of Cyclophilin Inhibitor NIM811 with Hepatitis C Virus NS3-4A Protease or NS5B Polymerase Inhibitors Enhance Antiviral Activity and Suppress the Emergence of Resistance
- (2008) J. E. Mathy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Preclinical Characteristics of the Hepatitis C Virus NS3/4A Protease Inhibitor ITMN-191 (R7227)
- (2008) S. D. Seiwert et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Molecular Mechanism of Hepatitis C Virus Replicon Variants with Reduced Susceptibility to a Benzofuran Inhibitor, HCV-796
- (2008) A. Y. M. Howe et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Selected Replicon Variants with Low-Level In Vitro Resistance to the Hepatitis C Virus NS5B Polymerase Inhibitor PSI-6130 Lack Cross-Resistance with R1479
- (2008) S. Ali et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Hepatitis C Virus Replicon Presents a Higher Barrier to Resistance to Nucleoside Analogs than to Nonnucleoside Polymerase or Protease Inhibitors
- (2008) M. F. McCown et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Thiazolides: a new class of drugs for the treatment of chronic hepatitis B and C
- (2008) Jean-François Rossignol et al. Future Microbiology
- Silibinin Is a Potent Antiviral Agent in Patients With Chronic Hepatitis C Not Responding to Pegylated Interferon/Ribavirin Therapy
- (2008) Peter Ferenci et al. GASTROENTEROLOGY
- Improved Virologic Response in Chronic Hepatitis C Genotype 4 Treated With Nitazoxanide, Peginterferon, and Ribavirin
- (2008) Jean–François Rossignol et al. GASTROENTEROLOGY
- R1626 plus peginterferon Alfa-2a provides potent suppression of hepatitis C virus RNA and significant antiviral synergy in combination with ribavirin
- (2008) Paul J. Pockros et al. HEPATOLOGY
- High relapse rate seen at week 72 for patients treated with R1626 combination therapy
- (2008) Paul Pockros et al. HEPATOLOGY
- The cyclophilin inhibitor Debio-025 shows potent anti-hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus
- (2008) Robert Flisiak et al. HEPATOLOGY
- Robust antiviral activity of R1626, a novel nucleoside analog: A randomized, placebo-controlled study in patients with chronic hepatitis C
- (2008) Stuart K. Roberts et al. HEPATOLOGY
- Telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in chronic hepatitis C patients
- (2008) Stefan Zeuzem JOURNAL OF HEPATOLOGY
- Treatment failure in hepatitis C: Mechanisms of non-response
- (2008) Andrew W. Tai et al. JOURNAL OF HEPATOLOGY
- Targeting Lipid Metabolism in the Treatment of Hepatitis C Virus Infection
- (2008) Fumitake Amemiya et al. JOURNAL OF INFECTIOUS DISEASES
- Cyclophilin A Is an Essential Cofactor for Hepatitis C Virus Infection and the Principal Mediator of Cyclosporine Resistance In Vitro
- (2008) F. Yang et al. JOURNAL OF VIROLOGY
- Discovery of a hepatitis C target and its pharmacological inhibitors by microfluidic affinity analysis
- (2008) Shirit Einav et al. NATURE BIOTECHNOLOGY
- Essential Role of Domain III of Nonstructural Protein 5A for Hepatitis C Virus Infectious Particle Assembly
- (2008) Nicole Appel et al. PLoS Pathogens
- Nitazoxanide, tizoxanide and other thiazolides are potent inhibitors of hepatitis B virus and hepatitis C virus replication
- (2007) Brent E. Korba et al. ANTIVIRAL RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More